Skip to main content

Oral nutritional supplements promote significant weight gain in cystic fibrosis patients

Buy Article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

Abstract:

Background: Malnutrition and poor growth are major problems for many patients with cystic fibrosis (CF), and nutritional supplements can enhance the success of dietary strategies. The purpose of this study was to assess Scandishake (Scandipharm Ltd, U.K.), an energy dense (2.0 kcal/ml) oral supplement.Methods: The study design included a 4-week monitoring period, followed by 8 weeks of supplementation with Scandishake. The subjects had anthropometry assessed at weeks 0, 4 and 12, and their dietary intake assessed at weeks 0 and 12.

Results: Data from 26 patients (16 male, 10 female; age range 9-34 years) showed a significant mean weight increase of 1.9 kg (range 1.6-4 kg) and a mean increase of 0.5 cm (range 1.1-2.7 cm) in mid-arm muscle circumference. There was also an increase in energy intakes, rising from a mean of 11.15 MJ (2665 kcals) to a mean of 13.42 MJ (3208 kcals) (P < 0.01), and the mean of individual percentages of estimated average requirement (EAR) for energy increased from 120% (73-182%) to 143% (67-221%).

Conclusion: The energy dense formulation of Scandishake makes it a useful adjunct in the treatment of malnutrition and the promotion of normal growth in patients with CF.

Keywords: cystic fibrosis; malnutrition; oral nutritional supplements; weight gain

Document Type: Research Article

Affiliations: 1: Nottingham City Hospital 2: St. James' and Seacroft University Hospitals, Leeds 3: Birmingham Children's Hospital 4: University Hospital, Belfast 5: Head of Dietetics, Nutrition and Dietetic Department, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK.

Publication date: 1998-04-01

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more